Vimarsana
Biggest News Aggregation in the World

Page 3 - Robert Yu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Yu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Yu Today - Breaking & Trending Today

Why Honolulu Hale Keeps Stealing State Appointees To HART - Vimarsana News

Why Honolulu Hale Keeps Stealing State Appointees To HART

The difficulty finding qualified volunteers to fill board seats is another sign of the chaos that has plagued the troubled rail project.

Owner of small house surrounded by huge apartments on Walker Street in Rhodes REFUSES to sell - Vimarsana News

Owner of small house surrounded by huge apartments on Walker Street in Rhodes REFUSES to sell

The elderly owner of a rundown Sydney house surrounded by high-rise apartment buildings refuses to sell her humble home to developers for less than $20million - even as new residents bizarrely label her home an eyesore.

Yuyu Pharma aims to grow bigger with dry eye, hair loss drugs - Vimarsana News

Yuyu Pharma aims to grow bigger with dry eye, hair loss drugs

FRANKFURT - Robert Yu, president and CEO of Yuyu Pharma, said Wednesday that his mission is to make the company comparable to prominent biopharmaceutical companies in the world. To that end, he said the Korean company is actively diversifying its portfolio by developing new drugs such as a dry eye treatment as well as hair loss medication.

Yuyu Pharma attendance at European Pharmaceutical Conference - Vimarsana News

Yuyu Pharma attendance at European Pharmaceutical Conference

/PRNewswire/ -- Robert Yu, CEO of Yuyu Pharma, has been attending biopharmaceutical conferences held in Germany, BIO-Europe and CPHI. The purpose is to explore...

Yuyu Pharma Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating YP-P10 Ophthalmic Solution for the Treatment of Dry Eye Disease - Vimarsana News

Yuyu Pharma Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating YP-P10 Ophthalmic Solution for the Treatment of Dry Eye Disease

/PRNewswire/ -- Yuyu Pharma announces the enrollment of the first patient in a phase 2 clinical study evaluating YP-P10, a novel and patented synthetic peptide...